{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:56Z","timestamp":1788307736626,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.amepre.2010.05.022","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T04:56:02Z","timestamp":1284612962000},"page":"296-304","source":"Crossref","is-referenced-by-count":49,"title":["Evaluation of Guillain-Barr\u00e9 Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001"],"prefix":"10.1016","volume":"39","author":[{"given":"Dale R.","family":"Burwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson W.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector S.","family":"Izurieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence La","family":"Voie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville A.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Miles","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amepre.2010.05.022_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the national influenza immunization program, U.S., 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.amepre.2010.05.022_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain-Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amepre.2010.05.022_bib3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain-Barr\u00e9 syndrome and receipt of swine influenza vaccine in 1976\u201377: results of a two-state study","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"25","key":"10.1016\/j.amepre.2010.05.022_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2010.05.022_bib5","series-title":"Immunization safety review: influenza vaccines and neurological complications","year":"2001"},{"issue":"20","key":"10.1016\/j.amepre.2010.05.022_bib6","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2010.05.022_bib7","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amepre.2010.05.022_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain-Barr\u00e9 syndrome in the United Kingdom, 1992 to 2000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Intern Med"},{"issue":"RR-3","key":"10.1016\/j.amepre.2010.05.022_bib9","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-6","key":"10.1016\/j.amepre.2010.05.022_bib10","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-10","key":"10.1016\/j.amepre.2010.05.022_bib11","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-7","key":"10.1016\/j.amepre.2010.05.022_bib12","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2010.05.022_bib13","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/507556","article-title":"Universal influenza vaccination in the U.S.: are we ready?","volume":"194","author":"Schwartz","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2010.05.022_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.30.9.929","article-title":"Fatal Guillain-Barr\u00e9 syndrome after the national immunization program","volume":"30","author":"Keenlyside","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.amepre.2010.05.022_bib16","first-page":"466","article-title":"Update: influenza activity\u2014U.S. and worldwide, 2000\u201301 season, and composition of the 2001\u201302 influenza vaccine","volume":"50","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"issue":"RR-4","key":"10.1016\/j.amepre.2010.05.022_bib17","first-page":"5","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"50","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2010.05.022_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.1390","article-title":"Evaluating adverse events after vaccination in the Medicare population","volume":"16","author":"Burwen","year":"2007","journal-title":"Pharmacoepidemiol Drug Safety"},{"issue":"S","key":"10.1016\/j.amepre.2010.05.022_bib19","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.amepre.2010.05.022_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"Diagnostic and classification criteria for the Guillain-Barr\u00e9 syndrome","volume":"45","author":"Van der Mech\u00e9","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.amepre.2010.05.022_bib21","first-page":"78","article-title":"Immunization safety review: influenza vaccines and neurological complications","year":"2001"},{"key":"10.1016\/j.amepre.2010.05.022_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2010.05.022_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jclinepi.2005.11.012","article-title":"Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations","volume":"59","author":"Glanz","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"S 2","key":"10.1016\/j.amepre.2010.05.022_bib25","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2010.05.022_bib26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2010.05.022_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-1331.2004.00799.x","article-title":"Guillain-Barr\u00e9 syndrome in Greece: seasonality and other clinico-epidemiological features","volume":"11","author":"Chroni","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.amepre.2010.05.022_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0404.2006.00731.x","article-title":"Guillain-Barr\u00e9 syndrome in northwest Greece","volume":"115","author":"Markoula","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.amepre.2010.05.022_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1468-1331.2000.00006.x","article-title":"Incidence of Guillain-Barr\u00e9 syndrome in Sweden 1996","volume":"7","author":"Cheng","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.amepre.2010.05.022_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1034\/j.1600-0404.2000.101002104.x","article-title":"Epidemiological surveillance of Guillain-Barr\u00e9 syndrome in Sweden, 1996\u20131997","volume":"101","author":"Cheng","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.amepre.2010.05.022_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10072-004-0231-6","article-title":"Public health surveillance and incidence of adulthood Guillain-Barr\u00e9 syndrome in Spain, 1998\u20131999: the view from a sentinel network of neurologists","volume":"25","author":"Cuadrado","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.amepre.2010.05.022_bib32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.248.6.698","article-title":"Guillain-Barr\u00e9 syndrome in the U.S., 1979\u20131980 and 1980\u20131981","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2010.05.022_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.33.5.633","article-title":"Guillain-Barr\u00e9 syndrome in the U.S., 1978\u20131981: additional observations from the national surveillance system","volume":"33","author":"Kaplan","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.amepre.2010.05.022_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/WNL.48.1.214","article-title":"A prospective study on the incidence and prognosis of Guillain-Barr\u00e9 syndrome in Emilia-Romagna region, Italy (1992\u20131993)","volume":"48","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.amepre.2010.05.022_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-510X(03)00215-6","article-title":"Is there a decrease in Guillain-Barr\u00e9 syndrome incidence after bovine ganglioside withdrawal in Italy?","volume":"216","author":"Govoni","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.amepre.2010.05.022_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0404.2004.00272.x","article-title":"Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996","volume":"110","author":"Bogliun","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.amepre.2010.05.022_bib37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-003-1096-y","article-title":"Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barr\u00e9 syndrome","volume":"250","author":"Odaka","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.amepre.2010.05.022_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.wnl.0000167549.09664.b8","article-title":"Distinguishing acute-onset CIDP from Guillain-Barr\u00e9 syndrome with treatment-related fluctuations","volume":"65","author":"Ruts","year":"2005","journal-title":"Neurology"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379710004101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379710004101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T16:41:00Z","timestamp":1559666460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379710004101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0749379710004101"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2010.05.022","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}